Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
Aged
Cardiac Surgical Procedures
/ adverse effects
Defibrillators
Electric Countershock
/ adverse effects
Electrocardiography
/ instrumentation
Equipment Design
Germany
Humans
Male
Middle Aged
Retrospective Studies
Risk Factors
Stroke Volume
Tachycardia, Ventricular
/ diagnosis
Time Factors
Treatment Outcome
Ventricular Fibrillation
/ diagnosis
Ventricular Function, Left
Journal
The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
21
6
2018
medline:
10
4
2019
entrez:
21
6
2018
Statut:
ppublish
Résumé
A wearable cardioverter-defibrillator (WCD) can terminate ventricular fibrillation and ventricular tachycardias via electrical shock and thus give transient protection from sudden cardiac death. We investigated its role after cardiac surgery. We retrospectively analyzed all patients who were discharged with a WCD from cardiac surgery department. The WCD was prescribed for patients with a left ventricular ejection fraction (LVEF) of ≤35% or an explanted implantable cardioverter-defibrillator (ICD). A total of 100 patients were included in this study, the majority ( Ventricular arrhythmias occurred in 13% of the investigated patients. LVEF improved significantly after 3 months, and thus a permanent ICD implantation was avoided in several cases. Sternotomy did not impair wearing time of the WCD. A WCD can effectively protect patients against ventricular tachyarrhythmias after cardiac surgery.
Sections du résumé
BACKGROUND
A wearable cardioverter-defibrillator (WCD) can terminate ventricular fibrillation and ventricular tachycardias via electrical shock and thus give transient protection from sudden cardiac death. We investigated its role after cardiac surgery.
METHODS
We retrospectively analyzed all patients who were discharged with a WCD from cardiac surgery department. The WCD was prescribed for patients with a left ventricular ejection fraction (LVEF) of ≤35% or an explanted implantable cardioverter-defibrillator (ICD).
RESULTS
A total of 100 patients were included in this study, the majority (
CONCLUSION
Ventricular arrhythmias occurred in 13% of the investigated patients. LVEF improved significantly after 3 months, and thus a permanent ICD implantation was avoided in several cases. Sternotomy did not impair wearing time of the WCD. A WCD can effectively protect patients against ventricular tachyarrhythmias after cardiac surgery.
Identifiants
pubmed: 29925094
doi: 10.1055/s-0038-1660802
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
92-97Informations de copyright
Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
All the authors have nothing to disclose.